Nanox to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
Nanox to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
PETAH TIKVA, Israel, March 18, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2023, before market open on Monday, April 1, 2024. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.
以色列佩塔提克瓦，2024年3月18日（環球新聞專線）——創新醫學成像技術公司NANO-X IMAGING LTD（納斯達克股票代碼：NNOX）（“Nanox” 或 “公司”）今天宣佈，將在2024年4月1日星期一開市前公佈截至2023年12月31日的季度和財年的財務業績。首席執行官埃雷茲·梅爾策和首席財務官蘭·丹尼爾將主持電話會議，審查這些業績，並從美國東部時間上午 8:30 開始提供業務最新情況。
Interested parties may register for the conference call using the following link: Nanox Q4 Earnings Call Registration. You may access the live webcast of the conference call by using the following link: Nanox Q4 Earnings Call Webcast. The link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations.
有興趣的人士可以使用以下鏈接註冊電話會議： Nanox 第四季度業績電話會議註冊。您可以使用以下鏈接訪問電話會議的網絡直播： Nanox 第四季度業績電話會議網絡直播。該鏈接還將發佈在Nanox網站的 “投資者關係” 部分，網址爲 活動和演講。
About Nanox
關於 Nanox
Nanox (NASDAQ: NNOX) is focused on applying its proprietary medical imaging technology and solutions to make diagnostic medicine more accessible and affordable across the globe. Nanox's vision is to increase access, reduce costs and enhance the efficiency of routine medical imaging technology and processes, in order to improve early detection and treatment, which Nanox believes is key to helping people achieve better health outcomes, and, ultimately, to save lives. The Nanox ecosystem includes Nanox.ARC— a multi-source Digital Tomosynthesis system that is cost-effective and user-friendly; an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic disease (Nanox AI); a cloud-based infrastructure (Nanox.CLOUD); and a proprietary decentralized marketplace, through Nanox's subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts; and a comprehensive teleradiology services platform (Nanox.MARKETPLACE). Together, Nanox's products and services create a worldwide, innovative and comprehensive solution that connects medical imaging solutions, from scan to diagnosis. For more information, please visit www.nanox.vision.
Nanox（納斯達克股票代碼：NNOX）專注於應用其專有的醫學成像技術和解決方案，使診斷藥物在全球範圍內更容易獲得和負擔得起。Nanox的願景是增加常規醫學成像技術和流程的可及性，降低成本並提高其效率，以改善早期發現和治療，Nanox認爲這是幫助人們獲得更好的健康結果並最終挽救生命的關鍵。Nanox生態系統包括Nanox.arc——一種具有成本效益且用戶友好的多源數字斷層合成系統；一套基於人工智能的算法，可增強常規CT成像的讀數，以突出通常與慢性病相關的早期症狀（Nanox AI）；基於雲的基礎設施（Nanox.Cloud）；以及通過Nanox的子公司USARAD Holdings Inc.提供的專有去中心化市場，爲放射學和心臟病學專家提供遠程訪問；以及一個全面的遠程放射學服務平台（Nanox.Marketplace）。Nanox 的產品和服務共同創造了一個全球性、創新性和全面的解決方案，將從掃描到診斷的醫學成像解決方案連接起來。欲了解更多信息，請訪問 www.nanox.vision。
Contacts
聯繫人
Media Contact:
媒體聯繫人：
Ben Shannon
ICR Westwicke
NanoxPR@icrinc.com
本·香農
ICR Westwicke
NanoxPR@icrinc.com
Investor Contact:
投資者聯繫人：
Mike Cavanaugh
ICR Westwicke
mike.cavanaugh@westwicke.com
邁克·卡瓦諾
ICR Westwicke
mike.cavanaugh@westwicke.com